Anbio Biotechnology (NNNN) is a Health Care company in the In Vitro & In Vivo Diagnostic Substances industry (SEC CIK 0001982708). Annual revenue was $0.01B in FY2025, compared to $0.02B in FY2022. Net income in FY2025 was $0.01B (diluted EPS $0.15).
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 |
|---|---|---|---|---|
| Revenue | $0.01B | $0.01B | $0.01B | $0.02B |
| Gross Profit | $0.01B | $0.01B | $0.00B | $0.01B |
| Operating Income | $0.01B | $0.00B | $0.00B | $0.01B |
| Net Income | $0.01B | $0.00B | $0.00B | $0.01B |
| EPS (Diluted) | $0.15 | $0.06 | $0.10 | $100112.00 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 |
|---|---|---|---|---|
| Total Assets | $0.03B | $0.02B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 |
|---|---|---|---|---|
| Operating Cash Flow | $-0.01B | $0.00B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 |
|---|---|---|---|---|
| Gross Margin | 87.2% | 71.9% | 50.1% |
Showing the most recent 4 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $0.02B |
| — |
| Total Liabilities | $0.00B | $0.00B | $0.00B | — |
|---|
| Stockholders' Equity | $0.03B | $0.02B | $0.01B | $0.01B |
|---|
| Cash & Equivalents | $0.01B | $0.01B | $0.01B | $0.01B |
|---|
| Total Debt | — | — | — | — |
|---|
| $0.00B |
| $0.00B |
| Capital Expenditures | — | — | — | — |
|---|
| Free Cash Flow | — | — | — | — |
|---|
| 53.4% |
| Operating Margin | 0.7% | 0.2% | 0.3% | 0.4% |
|---|
| Net Margin | 0.7% | 0.2% | 0.3% | 0.4% |
|---|
| Return on Equity | 21.2% | 13.8% | 15.2% | 79.8% |
|---|
| Return on Assets | 21.2% | 12.5% | 14.3% | — |
|---|
| Debt / Equity | 0.00× | 0.10× | 0.07× | — |
|---|
